JP2009508507A5 - - Google Patents

Download PDF

Info

Publication number
JP2009508507A5
JP2009508507A5 JP2008531620A JP2008531620A JP2009508507A5 JP 2009508507 A5 JP2009508507 A5 JP 2009508507A5 JP 2008531620 A JP2008531620 A JP 2008531620A JP 2008531620 A JP2008531620 A JP 2008531620A JP 2009508507 A5 JP2009508507 A5 JP 2009508507A5
Authority
JP
Japan
Prior art keywords
cell population
cells
ifn
cell
treg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008531620A
Other languages
English (en)
Japanese (ja)
Other versions
JP5925408B2 (ja
JP2009508507A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/009244 external-priority patent/WO2007039150A2/en
Publication of JP2009508507A publication Critical patent/JP2009508507A/ja
Publication of JP2009508507A5 publication Critical patent/JP2009508507A5/ja
Application granted granted Critical
Publication of JP5925408B2 publication Critical patent/JP5925408B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008531620A 2005-09-23 2006-09-22 免疫調節活性を有する細胞集団、単離方法および使用 Active JP5925408B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05077186.4 2005-09-23
EP05077186 2005-09-23
PCT/EP2006/009244 WO2007039150A2 (en) 2005-09-23 2006-09-22 Cell populations having immunoregulatory activity, method for isolation and uses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014118859A Division JP6089004B2 (ja) 2005-09-23 2014-06-09 免疫調節活性を有する細胞集団、単離方法および使用

Publications (3)

Publication Number Publication Date
JP2009508507A JP2009508507A (ja) 2009-03-05
JP2009508507A5 true JP2009508507A5 (enExample) 2009-09-24
JP5925408B2 JP5925408B2 (ja) 2016-05-25

Family

ID=37708240

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008531620A Active JP5925408B2 (ja) 2005-09-23 2006-09-22 免疫調節活性を有する細胞集団、単離方法および使用
JP2014118859A Active JP6089004B2 (ja) 2005-09-23 2014-06-09 免疫調節活性を有する細胞集団、単離方法および使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014118859A Active JP6089004B2 (ja) 2005-09-23 2014-06-09 免疫調節活性を有する細胞集団、単離方法および使用

Country Status (19)

Country Link
US (5) US20090130067A1 (enExample)
EP (4) EP3184631B1 (enExample)
JP (2) JP5925408B2 (enExample)
KR (2) KR101536239B1 (enExample)
CN (2) CN101313062A (enExample)
AU (1) AU2006299144A1 (enExample)
CA (2) CA2623353C (enExample)
CY (1) CY1117972T1 (enExample)
DK (1) DK1926813T4 (enExample)
ES (2) ES2751692T3 (enExample)
HU (1) HUE030503T2 (enExample)
IL (3) IL190363A0 (enExample)
LT (1) LT1926813T (enExample)
MX (1) MX342474B (enExample)
PL (1) PL1926813T5 (enExample)
PT (1) PT1926813T (enExample)
SG (3) SG165418A1 (enExample)
SI (1) SI1926813T2 (enExample)
WO (1) WO2007039150A2 (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
JP5925408B2 (ja) 2005-09-23 2016-05-25 タイジェニックス、ソシエダッド、アノニマ、ウニペルソナルTigenix S.A.U. 免疫調節活性を有する細胞集団、単離方法および使用
DK2347775T3 (da) 2005-12-13 2020-07-13 Harvard College Skabeloner til celletransplantation
US7989173B2 (en) 2006-12-27 2011-08-02 The Johns Hopkins University Detection and diagnosis of inflammatory disorders
US10328133B2 (en) 2008-02-13 2019-06-25 President And Fellows Of Harvard College Continuous cell programming devices
EP2282748B1 (en) 2008-03-28 2016-11-09 Stemcyte, Inc. Treatment of brain damage using umbilical cord blood cells
HUE037973T2 (hu) * 2008-04-17 2018-09-28 Io Biotech Aps Indolamin-2,3-dioxigenáz-alapú immunterápia
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
AU2009201915C1 (en) 2008-08-22 2015-02-26 Regeneus Ltd Therapeutic methods
EP2204442A1 (en) * 2008-10-01 2010-07-07 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Method of enriching stem cells in culture
GB0820397D0 (en) 2008-11-07 2008-12-17 Cellerix Sa Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases
KR101788885B1 (ko) 2009-07-09 2017-10-20 타이제닉스, 에스.에이.유. 세포 요법에 사용하기 위한 방법 및 조성물
WO2011014871A1 (en) * 2009-07-31 2011-02-03 President And Fellows Of Harvard College Programming of cells for tolerogenic therapies
US9005616B2 (en) 2009-08-31 2015-04-14 Amplimmune, Inc. Methods and compositions for the inhibition of transplant rejection
GB0918615D0 (en) * 2009-10-23 2009-12-09 Cellerix Sa Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
CN107648668B (zh) 2010-10-06 2021-06-18 哈佛学院董事会 用于基于材料的细胞疗法的可注射的成孔水凝胶
EP2663316A2 (en) 2011-01-12 2013-11-20 TiGenix, S.A.U. Adipose-derived mesenchymal stem cells for intralymphatic administration in autoimmune and inflammatory diseases
JP2014508527A (ja) * 2011-03-11 2014-04-10 ティゲニクス、エセ、ア、ウ 免疫調節活性を有する細胞集団、単離方法および使用
CN109432502A (zh) * 2011-04-25 2019-03-08 南加州大学 一种用于修复头盖缺陷的植入物
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
WO2012156522A1 (en) 2011-05-19 2012-11-22 Tigenix Sa Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
CN104244929B (zh) 2012-04-16 2017-04-05 哈佛学院董事会 用于调节免疫反应的介孔二氧化硅组合物
JP6412933B2 (ja) * 2013-06-25 2018-10-24 ティジェニクス エス.エー.ユー. 免疫調節活性を有する細胞集団、その調製方法および使用
US20150037436A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
JP6702866B2 (ja) 2013-11-18 2020-06-03 ルビウス セラピューティクス, インコーポレイテッド 合成膜−レシーバー複合体
WO2015153102A1 (en) 2014-04-01 2015-10-08 Rubius Therapeutics, Inc. Methods and compositions for immunomodulation
US10682400B2 (en) 2014-04-30 2020-06-16 President And Fellows Of Harvard College Combination vaccine devices and methods of killing cancer cells
SG11201610844PA (en) 2014-06-30 2017-01-27 Tigenix S A U Mesenchymal stromal cells for treating sepsis
JP6722598B2 (ja) 2014-06-30 2020-07-15 ティジェニクス エス.エー.ユー. 関節リウマチ治療のための間葉系間質細胞
JP2016017068A (ja) * 2014-07-10 2016-02-01 国立大学法人金沢大学 脂肪組織由来間質細胞群を含む消化管炎症治療剤
KR101675521B1 (ko) * 2014-07-11 2016-11-17 대한민국 인돌아민 2,3-디옥시게나아제를 이용하여 인터페론-감마의 발현을 조절하는 방법
EP3250250A4 (en) 2015-01-30 2019-05-22 President and Fellows of Harvard College PERITUMORAL AND INTRATUMORAL MATERIALS FOR CANCER THERAPY
JP7094533B2 (ja) 2015-04-10 2022-07-04 プレジデント アンド フェローズ オブ ハーバード カレッジ 免疫細胞捕捉デバイスおよびその製造および使用方法
EP3297694A1 (en) 2015-05-21 2018-03-28 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
EP3411475B1 (en) 2016-02-06 2025-08-27 President and Fellows of Harvard College Recapitulating the hematopoietic niche to reconstitute immunity
EP3419635B1 (en) 2016-02-22 2022-01-05 Centauri Biotech, S.L. Pharmaceutical or veterinary cell compositions comprising mesenchymal stromal cells (mscs) and dimethyl sulfoxide (dmso)
GB201604304D0 (en) 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
CN115537372A (zh) 2016-07-13 2022-12-30 哈佛学院院长等 抗原呈递细胞模拟支架及其制备和使用方法
EP3493842A4 (en) 2016-08-02 2020-07-29 President and Fellows of Harvard College BIOMATERIALS TO MODULATE IMMUNE RESPONSES
AU2018234827B2 (en) 2017-03-15 2024-04-04 Orca Biosystems Inc. Compositions and methods for hematopoietic stem cell transplants
US20210008120A1 (en) 2018-03-13 2021-01-14 Oxacell Ag Cell products with improved stability and uses thereof
CA3103043A1 (en) 2018-06-15 2019-12-19 Luis Marinas Pardo Pharmaceutical composition for dermatology and uses thereof
WO2020061129A1 (en) 2018-09-19 2020-03-26 President And Fellows Of Harvard College Compositions and methods for labeling and modulation of cells in vitro and in vivo
KR20210149148A (ko) * 2019-05-21 2021-12-08 이엠오 바이오메디슨 코퍼레이션 면역-관련 질환 치료에서의 중간엽 줄기 세포의 용도
JP2023512072A (ja) * 2020-01-30 2023-03-23 モデルナティエックス インコーポレイテッド 代謝リプログラミングポリペプチドをコードするmRNA及びその使用
KR102438419B1 (ko) * 2021-12-01 2022-09-01 메디포스트(주) Cd47 과발현 중간엽 줄기세포를 포함하는 폐 질환 예방 또는 치료용 조성물

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145770A (en) 1990-06-04 1992-09-08 Biosurface Technology, Inc. Cryopreservation of cultured epithelial sheets
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5733542A (en) * 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US6010696A (en) 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
JPH10505250A (ja) 1994-06-06 1998-05-26 ケース ウエスターン リザーブ ユニバーシティ 組織再生のためのバイオマトリックス
US6174333B1 (en) 1994-06-06 2001-01-16 Osiris Therapeutics, Inc. Biomatrix for soft tissue regeneration using mesenchymal stem cells
CN1166773C (zh) * 1997-12-02 2004-09-15 泽恩比奥公司 分离的人脂肪组织衍生的基质细胞
WO1999029852A1 (en) 1997-12-05 1999-06-17 Medical College Of Georgia Research Institute, Inc. High-affinity tryptophan transporter
ATE265220T1 (de) 1998-02-04 2004-05-15 Gen Hospital Corp Kostimulatorische blockade und gemischter chimerismus in allotransplantationen
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US9585916B2 (en) 1999-03-26 2017-03-07 Northern Therapeutics Inc. Cell based therapy for the pulmonary system
US6797269B2 (en) * 1998-04-03 2004-09-28 Osiris Therapeutics, Inc. Mesenchymal stem cells as immunosuppressants
CN1352696A (zh) 1999-03-10 2002-06-05 匹兹堡大学联邦制高等教育 脂肪来源的干细胞和网格
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20050153442A1 (en) 1999-03-10 2005-07-14 Adam Katz Adipose-derived stem cells and lattices
US20030082152A1 (en) 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
US7670628B2 (en) 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
US6555374B1 (en) 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
US7078232B2 (en) 1999-08-19 2006-07-18 Artecel, Inc. Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof
EP1257282A4 (en) 1999-12-06 2003-05-02 Gen Hospital Corp PANCREATIC STEM CELLS AND THEIR USE IN TRANSPLANTATION
CA2438904C (en) 2001-02-23 2012-09-04 The University Of Pittsburgh Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
EP1241249A1 (en) * 2001-03-12 2002-09-18 Gerold Schuler CD4+CD25+regulatory T cells from human blood
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
CN1596303A (zh) 2001-11-09 2005-03-16 阿特塞尔科学公司 利用基质细胞支持胚胎干细胞和成体干细胞的方法和组合物
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
CA2470763A1 (en) * 2001-12-18 2003-06-26 Mondobiotech Laboratories Anstalt Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
US7282222B2 (en) 2002-03-15 2007-10-16 The United States Of America As Represented By The Department Of Veterans Affairs Methods and compositions for directing cells to target organs
DE60318706T2 (de) 2002-06-14 2009-04-30 Cartela R & D Ab Marker für stammzellen und dessen verwendung
US20040204458A1 (en) * 2002-08-16 2004-10-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of Lck inhibitors for treatment of immunologic diseases
US20040101959A1 (en) 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells
WO2004090095A2 (en) * 2003-04-01 2004-10-21 University Of Southern California Generation of human regulatory t cells by bacterial toxins for the treatment of inflammatory disorders
CA2521217C (en) 2003-04-01 2013-05-14 United States Of America Department Of Veteran's Affairs Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
ES2265199B1 (es) 2003-06-12 2008-02-01 Cellerix, S.L. Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones.
CA2530421C (en) 2003-06-27 2015-04-21 Ethicon, Incorporated Repair and regeneration of ocular tissue using postpartum-derived cells
US9074190B2 (en) 2003-10-07 2015-07-07 Biomaster, Inc. Cell differentiation of adipose-derived precursor cells
DE602004030823D1 (de) 2003-11-04 2011-02-10 Biomaster Inc Verfahren und system zur herstellung von stammzellen aus fettgewebe
JP2007517036A (ja) 2003-12-24 2007-06-28 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク 房室ブロックを補うための生物学的房室間バイパスの作製
CA2552891A1 (en) * 2004-01-08 2005-08-04 Regents Of The University Of California Regulatory t cells suppress autoimmunity
US20080095749A1 (en) 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
EP2298861B1 (en) 2004-03-22 2017-09-13 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
RU2252252C1 (ru) 2004-04-09 2005-05-20 Тепляшин Александр Сергеевич Способ выделения мезенхимальных стволовых клеток
ES2264862B8 (es) 2004-08-25 2017-01-20 Cellerix, S.L. Biomaterial para sutura.
ES2313805B1 (es) 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
US7732126B2 (en) 2004-09-03 2010-06-08 University Of Maryland, Baltimore Integrin CD18 is a novel stromal stem cell marker and functions to promote osteogenesis
US20060286089A1 (en) 2005-04-08 2006-12-21 Xcyte Therapies, Inc. Compositions and methods for the treatment of burns and sepsis
JP5925408B2 (ja) 2005-09-23 2016-05-25 タイジェニックス、ソシエダッド、アノニマ、ウニペルソナルTigenix S.A.U. 免疫調節活性を有する細胞集団、単離方法および使用
EP1795588A1 (en) 2005-12-07 2007-06-13 Cellerix, S.L. Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
US20120269774A1 (en) 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
WO2009031606A1 (ja) 2007-09-07 2009-03-12 Jcr Pharmaceuticals Co., Ltd. 関節炎治療及び予防剤
CN107028981B (zh) 2007-09-19 2021-04-20 普拉里斯坦有限公司 来自脂肪或胎盘组织的粘附细胞及其在治疗中的用途
JP5539886B2 (ja) 2007-10-17 2014-07-02 ティクセル Tr1細胞、間葉系幹細胞およびその使用
GB0814249D0 (en) 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
ES2345867B1 (es) 2009-04-03 2011-07-28 Fundacion Instituto Mediterraneo Para La Biotecnologia Y La Investigacion Sanitaria (Imabis) Celulas madre multipotentes derivadas de estroma de mesenterio.
KR101788885B1 (ko) 2009-07-09 2017-10-20 타이제닉스, 에스.에이.유. 세포 요법에 사용하기 위한 방법 및 조성물
EP2663316A2 (en) 2011-01-12 2013-11-20 TiGenix, S.A.U. Adipose-derived mesenchymal stem cells for intralymphatic administration in autoimmune and inflammatory diseases
JP2014508527A (ja) 2011-03-11 2014-04-10 ティゲニクス、エセ、ア、ウ 免疫調節活性を有する細胞集団、単離方法および使用
US20140134140A1 (en) 2012-11-09 2014-05-15 Case Western Reserve University Mesenchymal stem cell compositions for the treatment of microbial infections
AU2014230014B2 (en) 2013-03-15 2019-11-14 Tigenix, S.A.U. Lymphocyte biomarkers for determining the clinical response to therapy with mesenschymal stromal cells(MSC)
JP6412933B2 (ja) 2013-06-25 2018-10-24 ティジェニクス エス.エー.ユー. 免疫調節活性を有する細胞集団、その調製方法および使用

Similar Documents

Publication Publication Date Title
JP2009508507A5 (enExample)
EP2298862B1 (en) Mesenchymal stem cells and uses therefor
KR101557256B1 (ko) 세포 증식 방법 및 세포의 용도 및 치료를 위해 그 세포에 의해 제조되는 조절된 배지
JP6548714B2 (ja) 放射線照射または化学物質による傷害を治療するための方法
Wang et al. The immunomodulatory activity of human umbilical cord blood‐derived mesenchymal stem cells in vitro
K. Batsali et al. Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications
CN104781394B (zh) 用于培养间充质干细胞的方法
Lv et al. Intrinsic properties of mesemchymal stem cells from human bone marrow, umbilical cord and umbilical cord blood comparing the different sources of MSC
KR20140040696A (ko) 간엽줄기세포 및 면역조절 t 세포를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물
CN108998411A (zh) 人子宫内膜组织来源间充质干细胞的分离培养方法
Petinati et al. Changing the properties of multipotent mesenchymal stromal cells by IFNγ administration
ES2643076T3 (es) Células madre mesenquimales y sus usos
JP6147419B2 (ja) 心臓内膜由来の成体幹細胞及びこれの製造方法
AU2012205269B2 (en) Mesenchymal stem cells and uses therefor
Sobh Adipogenesis of Sprague Dawely rats mesenchymal stem cells: a morphological, immunophenotyping and gene expression follow-up study
Yusoff et al. Generation and characterisation of human umbilical cord derived mesenchymal stem cells by explant method
RU2645255C1 (ru) Способ получения биобезопасной культуры мезенхимальных стволовых клеток из ворсин хориона человека
KR20250126855A (ko) 중간엽 줄기 세포 및 그에 대한 용도
Tanamai et al. Cloning efficiency of canine mesenchymal stem cells isolated from bone marrow of femoral head and subcutaneous adipose tissue
TW202224691A (zh) 用於治療骨骼缺損之體幹細胞
Busson et al. IV. Mesenchymal Stem Cells
Block et al. Use of MSCs in Antiaging Strategies
CN114181899A (zh) 一种从小鼠牙龈组织中获得间充质干细胞的方法
Bedi et al. Periodontal regeneration by stem cells therapy
Baustian PROSPECTIVE ISOLATION AND CHARACTERISATION OF MOUSE BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS